lupus
As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that patients outside of cancer may not accept.
FDA Approves Iaso Bio IND to Test CAR T-Cell Therapy in New Autoimmune Indications
The firm will test eque-cel, which is approved as a treatment for multiple myeloma in China, in systemic lupus erythematosus and lupus nephritis.
The New Jersey hospital system is enrolling patients into a Phase I clinical trial evaluating Bristol Myers Squibb's investigational cell therapy for lupus.
Kyverna Therapeutics' Cell Therapy Safe in First 30 Autoimmune Patients, Leads to Remission in Most
Premium
One patient who received a lower dose of the autologous CAR T-cell therapy KYV-101 for lupus nephritis has experienced recurrent disease.
Seattle Children's to Kick off CAR T-Cell Clinical Trial for Pediatric Lupus Patients This Summer
Premium
The autologous cell therapy, developed by Seattle Children's Therapeutics group, has previously been tested in cancer indications.